A rich investor has come to you for advice. She has been come up by a biochemist who seeks financial backing for a company that would market dinitropenol and dicumarol as weight-loss medications. The biochemist has defined to her that these agents are uncouplers and that they would dissipate metabolic energy as heat. The investor wants to know if you think she must invest in the biochemist's company. How would you respond?